Heterogeneity in NK Cell Subpopulations May Be Involved in Kidney Cancer Metastasis

Zhengfang Liang1,2,3, Fengwei Nong2,4, Jingjie Zhao5

  • 1Jinan University, Guangzou, Guangdong Province, China.

Insights

Researchers identified distinct natural killer (NK) cell groups in kidney cancer. Two specific NK cell types, NK(EGR1) and NK(CAPG), are linked to tumor metastasis and represent potential therapeutic targets.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Immunotherapy for kidney cancer shows variable patient response.
  • Tumor immune microenvironment and immune cell heterogeneity are crucial for effective kidney cancer treatment.
  • Understanding natural killer (NK) cell roles in clear cell renal cell carcinoma (ccRCC) is essential.

Purpose of the Study:

  • To investigate the heterogeneity of natural killer (NK) cell populations infiltrating clear cell renal cell carcinoma (ccRCC).
  • To identify specific NK cell subpopulations associated with ccRCC progression and metastasis.
  • To explore potential therapeutic targets within NK cells for inhibiting ccRCC metastasis.

Main Methods:

  • Isolation of NK cell populations from ccRCC and normal kidney tissues using single-cell sequencing data and signature genes.
  • Classification of NK cells into subpopulations (NK(GZMH), NK(EGR1), NK(CAPG)) based on gene expression profiles.
  • Gene set enrichment analysis to determine the functional roles of NK cell subpopulations.

Main Results:

  • Three distinct NK cell subpopulations were identified: NK(GZMH), NK(EGR1), and NK(CAPG).
  • NK(EGR1) and NK(CAPG) subpopulations were significantly associated with tumor metastasis.
  • These metastatic NK cell phenotypes were linked to specific cancers like Hodgkin lymphoma and T-cell leukaemia.

Conclusions:

  • Heterogeneity exists within infiltrating NK cells in kidney cancer.
  • The NK(EGR1) and NK(CAPG) subpopulations are promising therapeutic targets for inhibiting ccRCC metastasis.
  • Findings provide a reference for understanding NK cell-mediated metastasis mechanisms in kidney cancer.